In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nippon Roche acquires majority of Chugai

Executive Summary

Roche's Japanese subsidiary Nippon Roche and Chugai Pharmaceutical Co. will merge to form an R&D-driven Japanese pharmaceutical company, which will leverage the strengths of both. The new company will retain the Chugai name and continue its listing on the Tokyo Stock Exchange.

Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Stock

Related Companies